Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and Lapatinib in Advanced Solid Tumors and Breast Cancer
NCT01118975Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Mar 2010
- Primary completion
- Oct 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in HER2-positive breast cancer, solid tumor, sponsored by University of Maryland, Baltimore. Started Mar 2010; status: terminated.
02
Drugs
vorinostat
03
Conditions
HER2-positive breast cancersolid tumor
Beyond the preview
Go deeper on NCT01118975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118975.